Skip to main content

Lionsgate Studios Corp.

corporate_fare Company Profile

Lionsgate Studios Corp.

LION·NYSE·Trade & Services·CIK 0002052959

Lionsgate Studios Corp. is a standalone content company focused on motion picture and television production and distribution. The company operates with a portfolio of brands and franchises, includes the talent management and production company 3 Arts Entertainment, and manages a film and television library of more than 20,000 titles. Lionsgate Studios Corp. classifies its operations into two reportable business segments: Motion Picture and Television Production. The Motion Picture segment generates revenue from several sources. Theatrical revenue comes from the domestic theatrical release of motion pictures, licensed to exhibitors on a picture-by-picture basis. Distribution is handled directly in the U.S. and through a sub-distributor in Canada, with Canadian revenues reported net of distribution fees and release expenses. Financial terms with U.S. theatrical exhibitors generally involve a percentage of box office results. Theatrical revenues also include licenses to direct-to-platform customers for initial motion picture releases. Home Entertainment revenue is derived from the sale or rental of film productions, acquired or licensed films, and certain television programs (including theatrical and direct-to-video releases) on packaged media and through digital media platforms such as pay-per-view, video-on-demand, electronic sell-through, and digital rental. The company also has revenue sharing arrangements with certain digital media platforms, where it shares in rental or sales revenues generated by the platform on a title-by-title basis, often in exchange for a nominal or no upfront sales price. The Television segment also contributes to revenue.

Lionsgate Studios Corp. (NYSE:LION) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 14 items for LION at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for LION spans 10-Q, 8-K, SCHEDULE 13D/A, 10-K.

Recent high-impact activity:

  • Lionsgate Studios Q1 Revenue Surges 48% on 'Michael' Theatrical Blockbuster
  • Lionsgate Studios Q1 Revenue Surges 48% to $777M, Swings to Operating Profit
  • MHR Restructures Lionsgate Stake, Grants Lead Investor Board and Liquidity Rights
  • Lionsgate Studios Narrows FY26 Loss by 45% to $198M, Reports $2.63B Revenue
  • Lionsgate Studios Reports Strong FY2026 Results, Operating Income Turns Positive Post-Starz Separation

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$2.63B
Net Income
-$198.3M
Diluted EPS
-$0.70
Op. Cash Flow
$24.8M
Free Cash Flow
$11.4M
Operating Income
$97.1M
Cash & Equivalents
$341.5M
Total Debt
$1.94B
Debt / Equity
-1.63×
Net Margin
-7.5%
Shares Outstanding
285.4M sh
Source: 10-K · filed 2026-05-27 · accession 0002052959-26-000049

Short Interest & Short Volume

5.01 days to cover

FINRA reported short interest of 12,348,210 shares in LION as of the September 15, 2026 settlement, a 12.8% decrease from the prior period — about 5.0 days to cover at its recent average daily volume. On October 2, 2026, 50.4% of LION volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,348,210 shares as of September 15, 2026
Change vs prior period▼ 12.8%
Days to cover5.01 at avg daily volume of 2,462,919
Daily short volume (FINRA facilities)50.4% of 1,112,103 shares on October 2, 2026
5-day average short volume49.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for LION, detected from its recent SEC filings · based on capital-structure filings through 2026-06-05.

2 recent capital raises1 shelf registration

CEO Contract Extended · Significant Performance-Based Equity Grant

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$10.99 -0.17% today
52-week range · as of 2026-08-06 $5.65 – $16.7
Market cap
$3.32B
Volume
2.7M (1.0× avg)
3-mo avg 2.7M
Live data · 2026-10-05 02:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LION - Latest Insights

LION
Aug 06, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.49
Real-time Price: $10.99 info
Change: -$2.50 (-19%) info
Market Cap: $3.321B info
LION
Aug 06, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.20
Real-time Price: $10.99 info
Change: -$2.21 (-17%) info
Market Cap: $3.321B info
LION
Jul 09, 2026, 7:30 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $13.65
Real-time Price: $10.99 info
Change: -$2.66 (-19%) info
Market Cap: $3.321B info
LION
May 27, 2026, 5:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $14.00
Real-time Price: $10.99 info
Change: -$3.01 (-22%) info
Market Cap: $3.321B info
LION
May 27, 2026, 4:59 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $14.00
Real-time Price: $10.99 info
Change: -$3.01 (-22%) info
Market Cap: $3.321B info
LION
May 21, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.50
Real-time Price: $10.99 info
Change: -$2.51 (-19%) info
Market Cap: $3.321B info
LION
Apr 15, 2026, 4:15 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $10.66
Real-time Price: $10.99 info
Change: +$0.330 (+3%) info
Market Cap: $3.321B info
LION
Apr 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.66
Real-time Price: $10.99 info
Change: +$0.330 (+3%) info
Market Cap: $3.321B info
LION
Feb 05, 2026, 4:29 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.96
Real-time Price: $10.99 info
Change: +$2.03 (+23%) info
Market Cap: $3.321B info
LION
Feb 05, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.96
Real-time Price: $10.99 info
Change: +$2.03 (+23%) info
Market Cap: $3.321B info
LION
Feb 03, 2026, 5:14 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.79
Real-time Price: $10.99 info
Change: +$2.20 (+25%) info
Market Cap: $3.321B info
LION
Jan 27, 2026, 7:13 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $9.77
Real-time Price: $10.99 info
Change: +$1.22 (+12%) info
Market Cap: $3.321B info
LION
Jan 27, 2026, 8:00 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $9.63
Real-time Price: $10.99 info
Change: +$1.36 (+14%) info
Market Cap: $3.321B info
LION
Jan 26, 2026, 8:03 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.79
Real-time Price: $10.99 info
Change: +$1.20 (+12%) info
Market Cap: $3.321B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets